Search details
1.
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
Int J Mol Sci
; 19(12)2018 Dec 19.
Article
in English
| MEDLINE | ID: mdl-30572564
2.
Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
Stem Cells
; 34(9): 2429-42, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27299362
3.
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
Sci Transl Med
; 13(620): eabh0272, 2021 11 17.
Article
in English
| MEDLINE | ID: mdl-34788079
4.
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity.
Nat Biotechnol
; 38(11): 1317-1327, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32541958
5.
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma.
Front Oncol
; 9: 69, 2019.
Article
in English
| MEDLINE | ID: mdl-30863720
6.
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.
Blood Adv
; 2(3): 210-223, 2018 02 13.
Article
in English
| MEDLINE | ID: mdl-29386194
7.
Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.
Oncotarget
; 8(47): 81873-81879, 2017 Oct 10.
Article
in English
| MEDLINE | ID: mdl-29137229
8.
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.
Oncoimmunology
; 6(5): e1304336, 2017.
Article
in English
| MEDLINE | ID: mdl-28638725
9.
Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.
Cancer Res
; 76(23): 6802-6815, 2016 12 01.
Article
in English
| MEDLINE | ID: mdl-27671676
Results
1 -
9
de 9
1
Next >
>>